Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin
dc.contributor.author | Walsh, Jacinta | |
dc.contributor.author | Gheorghe, Cassandra Elise | |
dc.contributor.author | Lyte, Joshua M. | |
dc.contributor.author | van de Wouw, Marcel | |
dc.contributor.author | Boehme, Marcus | |
dc.contributor.author | Dinan, Timothy G. | |
dc.contributor.author | Cryan, John F. | |
dc.contributor.author | Griffin, Brendan T. | |
dc.contributor.author | Clarke, Gerard | |
dc.contributor.author | Hyland, Niall P. | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Yakult Bio-Science Foundation | en |
dc.contributor.funder | Joint Programming Initiative A healthy diet for a healthy life | en |
dc.date.accessioned | 2020-04-28T14:21:48Z | |
dc.date.available | 2020-04-28T14:21:48Z | |
dc.date.issued | 2020-04-26 | |
dc.date.updated | 2020-04-28T13:08:48Z | |
dc.description.abstract | Objectives: Our objective was to demonstrate microbial regulation of hepatic genes implicated in drug metabolism and transport using germ‐free (GF) mice and to explore the impact of a microbial metabolite, butyrate, and a prebiotic dietary intervention on hepatic gene expression in mice. Methods: Using reverse‐transcriptase PCR, we investigated cytochrome P450 (CYP) and multidrug‐resistance protein 1 (MDR1) expression in conventional, GF and colonised GF mice. To investigate the effects of butyrate, sodium butyrate (3 g/l) was administered for 21 days to conventional or GF mice. In the prebiotic study, young adult and middle‐aged mice received diet enriched with 10% fructo‐oligosaccharide (FOS)‐inulin for 14 weeks. Key findings: Colonisation of GF animals normalised expression of Cyp3a11 and Mdr1b to conventional levels. Butyrate upregulated Cyp2b10 in conventional mice (P < 0.05) but overall did not induce widespread changes in hepatic genes. FOS‐inulin increased Cyp3a13 expression and had the opposite effect on Mdr1a expression in young adult mice (P < 0.05). Age, on the other hand, influenced the prebiotic effect on Cyp2a4 expression (P < 0.01). Conclusion: The expression of hepatic genes implicated in drug metabolism and transport displays sensitivity to the microbiome, microbiome‐derived metabolites and a microbial‐targeted intervention. Our study may provide the impetus to explore microbiota‐targeted interventions in normalising host metabolic activity and reducing inter‐individual variability in drug pharmacokinetics. | en |
dc.description.sponsorship | Nature Research-Yakult (The Global Grants for Gut Health; Ref No. 626891); Joint Programming Initiative-a healthy diet for a healthy life ((JPI-HDHL) award, ‘A Menu for Brain Responses Opposing Stress-Induced Alternations in Cognition’ (AMBROSIAC; 15/JPHDHL/3270)) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Walsh, J., Gheorghe, C.E., Lyte, J.M., van de Wouw, M., Boehme, M., Dinan, T.G., Cryan, J.F., Griffin, B.T., Clarke, G. and Hyland, N.P. (2020) 'Gut microbiome‐mediated modulation of hepatic cytochrome P450 and P‐glycoprotein: impact of butyrate and fructo‐oligosaccharide‐inulin', Journal of Pharmacy and Pharmacology, doi: 10.1111/jphp.13276 | en |
dc.identifier.doi | 10.1111/jphp.13276 | en |
dc.identifier.endpage | 10 | en |
dc.identifier.issn | 2042-7158 | |
dc.identifier.journaltitle | Journal of Pharmacy and Pharmacology | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/9885 | |
dc.language.iso | en | en |
dc.publisher | Wiley | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/ | en |
dc.rights | © 2020 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology. This is the peer reviewed version of the following article: (2020), Gut microbiome‐mediated modulation of hepatic cytochrome P450 and P‐glycoprotein: impact of butyrate and fructo‐oligosaccharide‐inulin. J Pharm Pharmacol., which has been published in final form at https://doi.org/10.1111/jphp.13276 This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
dc.subject | Cytochrome | en |
dc.subject | Hepatic | en |
dc.subject | Metabolism | en |
dc.subject | Microbiome | en |
dc.subject | Transporter | en |
dc.title | Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Walsh_et_al._JPP-19-1008-clean.pdf
- Size:
- 455.33 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: